Patent ID: 11912764
Assignee: ALAMAB THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A pharmaceutical formulation comprising:
an anti-Cx43 antibody or antigen binding fragment thereof;
a buffer;
a surfactant; and
a stabilizer;
wherein the pharmaceutical formulation has a pH of between 5 and 6;
wherein the anti-Cx43 antibody or antigen binding fragment thereof comprises:
a first, second and third heavy chain complementarity determining region (CDR) sequence having the amino acid sequence of SEQ ID NOs: 1, 2, and 3, respectively; and
a first, second and third light chain CDR sequence having the amino acid sequence of SEQ ID NOs: 4, 5, and 6, respectively.